Lars Olof Hedbys

Lars Olof Hedbys

Director/Board Member presso CHOSA ONCOLOGY AB

67 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Lars Olof Hedbys was the founder of Idogen AB (founded in 2008) and held the title of Chief Executive Officer.
He is also the founder of Iampatient AB.
Currently, Dr. Hedbys is the Chief Executive Officer & Director at Vagnlyftaren AB, Chairman at Asgard Therapeutics AB, Chairman at Strominnate Therapeutics AB, Chairman at Vetiqure AB, Deputy Director at CanImGuide Therapeutics AB, Independent Director at Xintela AB, Deputy Director at Immodulate Pharma AB, Director at Cell Invent AB, Director & Partner at Ventac Partners AB, Director at Chosa Oncology AB, Director at Cell Invent Sweden AB, Partner at Ventac Partners GmbH, and Partner at Ventac Partners A.
In his former positions, Dr. Hedbys served as the Chief Executive Officer of Glycorex Transplantation AB, Mando AB, RhoVac AB, and Pharmiva AB.
He also held the role of Chairman at Lund Life Science Incubator, Chairman at Scandinavian ChemoTech AB (from 2020 to 2023), and Chairman at Smile Incubator AB (from 2011 to 2016).
Dr. Hedbys has also worked as a Director at Cartela AB, Regenesance BV, and Hamlet BioPharma AB, and as the General Manager at Synarc A.
He was a Vice President at Astrazeneca Alpha BV in 2014.
Additionally, Dr. Hedbys has a graduate degree from Chalmers University of Technology and a doctorate degree from the Faculty of Engineering, Lund University.

Posizioni attive di Lars Olof Hedbys

SocietàPosizioneInizio
XINTELA AB Director/Board Member 01/01/2021
CHOSA ONCOLOGY AB Director/Board Member 01/01/2023
Immodulate Pharma AB Director/Board Member -
Director/Board Member -
Ventac Partners AB Director/Board Member -
Vetiqure AB Chairman -
Chairman -
Cell Invent AB Director/Board Member -
Chairman -
░░░░░░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -
Tutte le posizioni attive di Lars Olof Hedbys

Precedenti posizioni note di Lars Olof Hedbys

SocietàPosizioneFine
░░░░░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Vedi nel dettaglio l'esperienza di Lars Olof Hedbys

Formazione di Lars Olof Hedbys

Chalmers University of Technology Graduate Degree
Faculty of Engineering, Lund University Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Lars Olof Hedbys

Relazioni

63

Relazioni di 1° grado

30

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa7
GLYCOREX TRANSPLANTATION AB

Health Technology

XINTELA AB

Health Technology

IDOGEN AB (PUBL)

Health Technology

HAMLET PHARMA AB (PUBL)

Health Technology

PHARMIVA AB (PUBL)

Commercial Services

SCANDINAVIAN CHEMOTECH AB

Health Technology

CHOSA ONCOLOGY AB

Commercial Services

Aziende private21

Health Technology

Health Services

Commercial Services

Health Technology

Synarc A/S

Astrazeneca Alpha BV

Retail Trade

Ventac Partners LLC

Commercial Services

Lund Life Science Incubator

Vagnlyftaren AB

Health Technology

Technology Services

Commercial Services

Commercial Services

Immodulate Pharma AB

Cell Invent AB

Commercial Services

Vetiqure AB

Ventac Partners AB

Commercial Services

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Lars Olof Hedbys